What is the treatment for impetiginization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetiginization

For impetiginization, topical mupirocin 2% ointment is the first-line treatment for limited lesions, while oral antibiotics are indicated for extensive disease or when topical therapy is impractical. 1

First-Line Treatment Options

Topical Therapy (Limited Disease)

  • Mupirocin 2% ointment: Apply to lesions 3 times daily for 5-7 days 2, 1, 3
    • Clinical efficacy rates of 71-96% 3
    • Effective against both Staphylococcus aureus and Streptococcus pyogenes 3
    • Superior to oral erythromycin in clinical studies 3, 4

Oral Antibiotics (Extensive Disease)

For patients with extensive impetiginization, systemic symptoms, or when topical therapy is impractical:

  1. First-line oral options (7-10 days of treatment):

    • Dicloxacillin: 250 mg 4 times per day (adults); 12 mg/kg/day in 4 divided doses (children) 2, 1
    • Cephalexin: 250-500 mg 4 times per day (adults); 25 mg/kg/day in 4 divided doses (children) 2, 1
  2. For penicillin-allergic patients:

    • Clindamycin: 300-400 mg 3 times per day (adults); 10-20 mg/kg/day in 3 divided doses (children) 2, 1
    • Erythromycin: 250 mg 4 times per day (adults); 40 mg/kg/day in 4 divided doses (children) 2
      • Note: Some strains of S. aureus and S. pyogenes may be resistant to erythromycin 2

MRSA Considerations

If MRSA is suspected or confirmed:

  • Topical: Continue mupirocin (still effective against many MRSA strains) 1
  • Oral options:
    • Clindamycin: 300-450 mg 3 times per day (adults); 10-20 mg/kg/day in 3 divided doses (children) 2
    • Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily (adults); 8-12 mg/kg/day based on trimethoprim component in 2 divided doses (children) 2
      • Note: TMP-SMX has inadequate streptococcal coverage 1, 5
    • Doxycycline: 100 mg twice per day (adults) 2
      • Not recommended for children <8 years of age 2
    • Linezolid: 600 mg twice daily (adults and children >12 years); 10 mg/kg/dose every 8 hours (children <12 years) 2

Special Pediatric Considerations

  • For children with minor impetiginization, mupirocin 2% topical ointment is the treatment of choice 2, 1
  • Tetracyclines (doxycycline, minocycline) should not be used in children <8 years of age 2
  • For hospitalized children with complicated skin infections, options include:
    • Vancomycin (first choice) 2
    • Clindamycin 10-13 mg/kg/dose IV every 6-8 hours (if local resistance rates are low) 2
    • Linezolid for children as noted above 2

Treatment Duration

  • Topical therapy: 5-7 days 1
  • Oral therapy: 7-10 days 1
  • Duration should be based on clinical response 2

Prevention of Recurrence and Spread

  • Keep draining wounds covered with clean, dry bandages 2
  • Maintain good personal hygiene with regular bathing and handwashing 2
  • Avoid sharing personal items (razors, linens, towels) 2
  • Focus cleaning on high-touch surfaces 2
  • Evaluate contacts for evidence of S. aureus infection 2

Clinical Pearls

  • Re-evaluate patients in 24-48 hours if using tetracyclines or trimethoprim-sulfamethoxazole to verify clinical response 1
  • Penicillin alone is not recommended as it is inferior to other antibiotics for impetiginization 6
  • Topical disinfectants are inferior to antibiotics and should not be used 5
  • Resistance patterns change over time and should be considered when selecting therapy 6

References

Guideline

Impetigo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.